サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1763311

マイクロ波アブレーションの世界市場

Microwave Ablation

出版日
ページ情報
英文 93 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円
マイクロ波アブレーションの世界市場
出版日: 2025年07月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 93 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

マイクロ波アブレーションの世界市場は2030年までに5億7,120万米ドルに達する見込み

2024年に2億7,120万米ドルと推定されるマイクロ波アブレーションの世界市場は、2024～2030年の分析期間中に13.2%のCAGRで成長し、2030年には5億7,120万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである肝臓がんは、CAGR 15.2%を記録し、分析期間終了時には2億1,550万米ドルに達すると予測されます。乳がん分野の成長率は、分析期間中CAGR 11.7%と推定されます。

米国市場は6,900万米ドルと推定、中国はCAGR17.3％で成長予測

米国のマイクロ波アブレーション市場は、2024年に6,900万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億4,050万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは17.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.9%と11.2%と予測されています。欧州では、ドイツがCAGR 10.2%で成長すると予測されています。

世界のマイクロ波アブレーション市場- 主要動向と促進要因まとめ

マイクロ波アブレーションとは何か、なぜ現代医療において重要なのか？

マイクロ波アブレーション（MWA）は、電磁波を使用して熱を発生させ、異常組織（主に腫瘍）を破壊する低侵襲医療処置です。この治療法では、細い針のようなプローブを標的組織に挿入し、そこからマイクロ波を照射して局所的な熱エネルギーを発生させています。この熱によって標的組織の細胞死を誘導し、がん細胞や異常細胞を効果的に破壊する一方、周囲の健康な組織は温存します。マイクロ波アブレーションは、肝臓、腎臓、肺、骨腫瘍などの様々ながんや、その他の軟部組織の異常の治療に広く使用されています。

マイクロ波アブレーションは、最小限の回復時間で効果的な治療を提供できることから、現代医学、特に腫瘍学において重要なツールとなっています。従来の手術に比べ、MWAは侵襲が少なく、外来で行うことができ、合併症の発生率も低いです。高齢、健康状態不良、腫瘍の位置などの理由で手術の適応とならない患者にとって、MWAは特に価値のある治療法です。MWAの精度と、手の届きにくい部位にある様々な大きさの腫瘍を治療する能力により、MWAはがん治療において多用途かつ重要な技術となっています。世界的にがんの罹患率が上昇を続ける中、マイクロ波アブレーションは、従来の治療法に代わる、革新的で効果的、かつ侵襲性の低い治療法を提供します。

マイクロ波アブレーションの主な用途と具体的な医療ニーズは？

マイクロ波アブレーションは、主にがん、特に肝臓、肺、腎臓、骨腫瘍の治療に応用されています。肝細胞がん（HCC）、つまり肝臓がんでは、MWAはその大きさ、数、位置のために外科的切除に適さない腫瘍を標的にするために使用されます。マイクロ波アブレーションは、早期の肝臓がん患者に対する手術の代替療法として、あるいは進行した腫瘍の患者に対する緩和治療として、しばしば採用されます。この技術は、腫瘍を精密かつ制御された方法で破壊する能力があるため、健康な肝臓組織を温存することが重要な肝臓がん治療において特に有用です。MWAは、大腸がんなど、体の他の部位に発生したがんの肝転移の治療にも有効であり、腫瘍学への応用をさらに広げています。

肺がんも、マイクロ波アブレーションが重要な役割を果たす分野です。手術の適応とならない早期の非小細胞肺がん（NSCLC）患者や、他の原発がんからの肺転移がある患者にとって、MWAは低侵襲治療の選択肢となります。この治療法では、周囲の肺組織へのダメージを避けながら、肺腫瘍を正確に狙い撃ちすることができます。このため、肺機能が低下している患者や、侵襲性の高い処置に耐えられない患者にとって理想的な治療法となります。肺がんや肝臓がんに加えて、腎臓（腎臓）腫瘍、特に腎摘除術や腎部分切除術が適さないような患者の小さな腎腫瘤の治療にも、マイクロ波アブレーションが使用されるようになってきています。MWAの正確な性質により、腎機能を可能な限り温存しながら、標的腫瘍を破壊することができます。

マイクロ波アブレーションは、がん細胞が他の臓器の原発腫瘍から骨に転移する骨転移の治療にも使用されます。骨転移は重大な痛みや構造的損傷を引き起こし、骨折や生活の質の低下につながります。MWAは、骨内の腫瘍組織を破壊することで、疼痛を管理し、骨を安定させる効果的な方法を提供します。転移性骨疾患患者の予後を改善するために、放射線治療や全身治療などの他の治療と併用されることも多いです。さらに、マイクロ波アブレーションは、副腎、甲状腺、前立腺がんなどの他の軟部腫瘍への応用も検討されており、腫瘍学における応用の可能性を広げています。

腫瘍学以外では、マイクロ波アブレーションは良性腫瘍や特定の非がん性疾患の治療にも応用されています。例えば、MWAは良性の甲状腺結節の治療に使用されますが、この結節は不快感、嚥下困難、美容上の懸念の原因となります。結節組織を切除することで、MWAは結節を小さくし、侵襲的な手術を必要とせずに症状を緩和します。同様に、マイクロ波アブレーションは前立腺肥大症（BPH）の治療にも使用されます。このような症例では、MWAを使用して前立腺を縮小し、排尿症状を緩和することで、従来の外科的処置に代わる低侵襲の選択肢を提供することができます。

マイクロ波アブレーションの多用途性は腫瘍治療だけにとどまらず、心血管系疾患への応用も研究されています。不規則な心拍の原因となる異常な心臓組織を切除することで、不整脈を治療するMWAの能力が研究されています。MWAの応用研究が進むにつれ、より広範な病状への利用が拡大し、低侵襲治療における重要なツールとしての地位が確固たるものになると期待されています。

技術の進歩はマイクロ波アブレーション市場にどのような影響を与えているか？

技術の進歩により、マイクロ波アブレーションの有効性、精度、安全性が大幅に向上し、臨床医と患者の双方にとってますます魅力的な選択肢となっています。マイクロ波アブレーション技術の主な発展の一つは、複数の腫瘍の同時切除を可能にする、より洗練されたマルチプローブシステムの開発です。これは、複数の肝転移や肺結節など、多病巣性の患者にとって特に重要です。複数のプローブを使用することで、臨床医は1回の治療でより広い範囲や複数の腫瘍を治療することができ、再治療の必要性を減らし、全体的な治療効率を向上させることができます。これらのマルチプローブシステムはまた、標的組織をより均一に加熱することができ、腫瘍全体を効果的に破壊することができます。

マルチ・プローブ・システムに加え、リアルタイム・イメージングとガイダンス技術の進歩は、マイクロ波アブレーション手技の精度を著しく高めています。超音波、コンピュータ断層撮影（CT）、磁気共鳴画像法（MRI）などの高解像度画像モダリティがアブレーションシステムと統合され、治療部位をリアルタイムで視覚化できるようになっています。これにより、臨床医はアブレーションプローブを正確に位置決めし、手技の進行状況をモニターすることができ、周囲の健康な組織へのダメージを最小限に抑えながら腫瘍を完全に切除することができます。リアルタイムのフィードバックはまた、マイクロ波エネルギーの出力と照射時間を調整するのに役立ち、処置の安全性と有効性を高めます。これらの画像処理の進歩は、血管や重要な臓器のような重要な構造の近くにある腫瘍の治療に特に価値があります。

もう一つの重要な技術開発は、マイクロ波アブレーションプローブの改良です。最新のアブレーションプローブは、より細く、より柔軟で、より丈夫に設計されており、体内への挿入が容易になり、狭い場所やアクセス困難な場所での操作性が向上しています。より小型で柔軟なプローブを使用することで、出血や感染などの合併症のリスクが軽減され、手技中および手技後の患者の快適性が向上します。さらに、アブレーションプローブの冷却機構の進歩により、放熱効率が向上し、周囲の組織をオーバーヒートさせることなく、高出力の照射が可能になりました。このようなプローブ設計の改善により、特にデリケートな部位や課題のある部位に腫瘍がある患者にとって、マイクロ波アブレーションはより安全で効果的な治療が可能になりつつあります。

腫瘍学の分野では、マイクロ波アブレーションと免疫療法や化学療法などの他の治療法との組み合わせに関する調査により、がん治療の成果を高める新たな可能性が開かれつつあります。MWAを全身療法と組み合わせることで、腫瘍に対する免疫反応を改善したり、腫瘍細胞を破壊して薬剤に弱くすることで化学療法の効果を高めたりできるかもしれないです。この相乗的アプローチは、進行がんや治療困難ながん患者に対して、より包括的で効果的な治療戦略を提供する可能性があります。このような併用療法を模索する臨床試験が進行中であり、初期の結果から、将来のがん治療において重要な役割を果たす可能性が示唆されています。

データ分析と人工知能（AI）の進歩も、マイクロ波アブレーション市場に影響を与え始めています。AI主導のソフトウェアツールは、臨床医がアブレーション手技を計画し最適化するのを支援するために開発されています。これらのツールは、腫瘍の大きさ、位置、周囲の解剖学的構造を含む患者データを分析し、最も適切なアブレーション・パラメータとプローブの配置を推奨することができます。個々の患者の特徴に基づいてパーソナライズされた治療計画を提供することで、AIは最善の結果を達成するために処置が調整されることを保証するのに役立ちます。さらに、AIベースのツールは、残存腫瘍組織や潜在的合併症を検出するために画像データを分析することにより、処置後のモニタリングを支援し、患者の長期的転帰を改善することができます。

最後に、ポータブルなマイクロ波アブレーションシステムの進歩により、特に外来患者や小規模な医療施設において、この技術へのアクセスが拡大しています。ポータブルアブレーション装置はコンパクトで持ち運びが容易であり、様々なヘルスケア環境に設置できるため、より多くの患者がこの治療法の恩恵を受けることが可能となります。ヘルスケアシステムが費用対効果が高く、侵襲の少ない治療をますます優先するようになるにつれて、ポータブルマイクロ波アブレーションシステムの利用可能性は拡大し、都市部と地方の両方の医療環境でこの技術をより広く採用できるようになると予想されます。

マイクロ波アブレーション市場の成長の原動力は？

マイクロ波アブレーション市場の成長は、世界のがん罹患率の上昇、低侵襲治療への嗜好の高まり、手技の安全性と有効性を高める技術の進歩など、いくつかの重要な要因によってもたらされます。主な要因のひとつは、世界のがん罹患率の増加です。世界保健機関（WHO）によると、がんは依然として世界の死因の第一位であり、毎年数百万人が新たにがんと診断されています。がん患者数が増加し続ける中、副作用を最小限に抑えながら治療成績を向上させる効果的な治療法に対する需要が高まっています。マイクロ波アブレーションは、多くの患者、特に手術不可能な腫瘍を持つ患者や侵襲の少ない治療法を求める患者にとって、従来の手術に代わる魅力的な選択肢を提供します。

低侵襲手術への嗜好の高まりも、マイクロ波アブレーション市場の成長に寄与する重要な要因です。患者もヘルスケアプロバイダーも、従来の開腹手術に比べて回復が早く、合併症が少なく、入院期間が短縮できる治療法を求めています。マイクロ波アブレーションは、外来患者ベースで、多くの場合局所麻酔下で行うことができ、一般的に痛みが少なく、通常の活動への復帰が早いため、これらの条件に合致しています。このような低侵襲治療への動向は、特に腫瘍学において顕著であり、マイクロ波アブレーションは、特に早期のがん患者や、基礎疾患のために手術の適応とならない患者に対して、より積極的な外科的アプローチに代わる選択肢を提供しています。

マイクロ波アブレーションシステムの技術的進歩も、手技の精度、安全性、有効性を向上させることで市場の成長を後押ししています。新しい画像技術やガイダンス技術によって、腫瘍を正確に狙い、健康な組織を避ける臨床医の能力が向上するにつれて、マイクロ波アブレーションの採用が拡大しています。さらに、より強力で効率的なアブレーション装置の開発とリアルタイムのモニタリング機能との組み合わせにより、より幅広い腫瘍の種類と大きさにおいて、この手技がより身近で効果的なものとなってきています。こうした技術革新は、病院と外来の両方でマイクロ波アブレーションの採用を増加させ、市場全体の成長に貢献しています。

特定のがんに対する第一選択治療としてのマイクロ波アブレーションの認知度向上と採用も、市場拡大に寄与しています。臨床医は、従来の手術ではリスクが高い、アクセスが困難な腫瘍や重要な構造物の近くにある腫瘍の治療におけるMWAの価値を認識しています。マイクロ波アブレーションは肝臓、肺、腎臓、骨など複数の臓器の腫瘍を治療できるため、様々ながんの治療において汎用性の高い選択肢となっています。さらに、幅広い腫瘍の治療におけるMWAの安全性と有効性が、より多くの臨床研究によって証明されるにつれ、標準的な治療法として受け入れられるようになってきています。

人口の高齢化と、肝疾患、腎疾患、肺疾患などの慢性疾患の有病率の増加が、マイクロ波アブレーションの需要をさらに押し上げています。世界人口の高齢化に伴い、肝硬変や肝炎など腫瘍の開発につながる可能性のある疾患の発生率が上昇しています。多くの高齢患者や合併症を持つ患者にとって、マイクロ波アブレーションは、より積極的な外科的介入に比べ、より安全で侵襲性の低い選択肢を提供します。慢性疾患や併存疾患を持つ患者の増加は、腫瘍学やその他の治療領域におけるMWAのさらなる採用を促進すると予想されます。

結論として、マイクロ波アブレーション市場は、世界のがん罹患率の上昇、低侵襲治療に対する需要の増加、手技の安全性、精度、有効性を向上させる継続的な技術進歩に牽引され、大きな成長を遂げようとしています。ヘルスケアプロバイダーが患者中心の費用対効果の高い治療を優先し続ける中、マイクロ波アブレーションの需要は今後数年で盛んになり、がん治療やそれ以外の分野でもその役割が拡大すると予想されます。

セグメント

アプリケーション（肝臓がん、乳がん、肺がん、前立腺がん、その他のアプリケーション）

調査対象企業の例

  • Angio Dynamics
  • Boston Scientific Corporation
  • Emblation microwave
  • Huber+Suhner
  • Johnson & Johnson Services Inc.
  • Med Waves
  • Medtronic PLC
  • MedWaves Inc.
  • Miramar labs
  • Neu Wave Medical
  • Pearson Medical
  • Symple Surgical
  • Urologix
  • Vison Medical USA Inc.

AIインテグレイションズ

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP17289

Global Microwave Ablation Market to Reach US$571.2 Million by 2030

The global market for Microwave Ablation estimated at US$271.2 Million in the year 2024, is expected to reach US$571.2 Million by 2030, growing at a CAGR of 13.2% over the analysis period 2024-2030. Liver Cancer, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$215.5 Million by the end of the analysis period. Growth in the Breast Cancer segment is estimated at 11.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$69.0 Million While China is Forecast to Grow at 17.3% CAGR

The Microwave Ablation market in the U.S. is estimated at US$69.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$140.5 Million by the year 2030 trailing a CAGR of 17.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.9% and 11.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.2% CAGR.

Global Microwave Ablation Market - Key Trends & Drivers Summarized

What Is Microwave Ablation, And Why Is It Crucial in Modern Medical Treatments?

Microwave ablation (MWA) is a minimally invasive medical procedure that uses electromagnetic waves to generate heat and destroy abnormal tissue, primarily tumors. The procedure involves the insertion of a thin, needle-like probe into the target tissue, through which microwaves are transmitted to create localized thermal energy. This heat induces cellular death in the targeted tissue, effectively destroying cancerous or abnormal cells while sparing the surrounding healthy tissue. Microwave ablation is widely used in the treatment of various cancers, including liver, kidney, lung, and bone tumors, as well as other soft-tissue abnormalities.

Microwave ablation is a crucial tool in modern medicine, particularly in oncology, due to its ability to offer effective treatment with minimal recovery time. Compared to traditional surgery, MWA is less invasive, can be performed on an outpatient basis, and is associated with lower complication rates. It is especially valuable for patients who are not candidates for surgery due to advanced age, poor health, or the location of the tumor. MWA’s precision and ability to treat tumors of varying sizes in hard-to-reach areas make it a versatile and vital technology in cancer treatment. As the global incidence of cancer continues to rise, microwave ablation offers an innovative, effective, and less invasive alternative to more traditional treatment modalities.

What Are the Main Applications of Microwave Ablation, And How Does It Serve Specific Medical Needs?

Microwave ablation is applied primarily in the treatment of cancerous tumors, particularly in patients with liver, lung, kidney, and bone tumors. In hepatocellular carcinoma (HCC), or liver cancer, MWA is used to target tumors that are not suitable for surgical resection due to their size, number, or location. Microwave ablation is often employed as an alternative to surgery for patients with early-stage liver cancer or as a palliative treatment for those with advanced-stage tumors. The technology’s ability to destroy tumors in a precise and controlled manner makes it particularly useful in liver cancer treatment, where preserving healthy liver tissue is critical. MWA is also effective in treating liver metastases from cancers originating in other parts of the body, such as colorectal cancer, further expanding its applications in oncology.

Lung cancer is another area where microwave ablation plays a significant role. For patients with early-stage non-small cell lung cancer (NSCLC) who are not candidates for surgery or those with lung metastases from other primary cancers, MWA offers a minimally invasive treatment option. The procedure allows for the precise targeting of lung tumors while avoiding damage to surrounding lung tissue. This makes it an ideal treatment for patients with compromised lung function or those unable to tolerate more invasive procedures. In addition to lung and liver cancer, microwave ablation is increasingly used to treat renal (kidney) tumors, particularly small renal masses in patients who may not be suitable for nephrectomy or partial nephrectomy. The precise nature of MWA allows for targeted tumor destruction, while preserving as much kidney function as possible.

Microwave ablation is also used in the treatment of bone metastases, where cancer cells spread to the bones from primary tumors in other organs. Bone metastases can cause significant pain and structural damage, leading to fractures and reduced quality of life. MWA provides an effective way to manage pain and stabilize bones by destroying tumor tissue within the bone. It is often combined with other therapies, such as radiation or systemic treatments, to improve outcomes for patients with metastatic bone disease. Furthermore, microwave ablation is being explored for use in other soft tissue tumors, such as adrenal, thyroid, and prostate cancers, expanding its potential applications in oncology.

Outside of oncology, microwave ablation has applications in the treatment of benign tumors and certain non-cancerous conditions. For example, MWA is used to treat benign thyroid nodules, which can cause discomfort, difficulty swallowing, or cosmetic concerns. By ablating the nodular tissue, MWA reduces the size of the nodule and alleviates symptoms without the need for more invasive surgery. Similarly, microwave ablation is used in the treatment of benign prostatic hyperplasia (BPH), a common condition in aging men characterized by an enlarged prostate. In these cases, MWA can be used to shrink the prostate and relieve urinary symptoms, offering a minimally invasive alternative to traditional surgical procedures.

The versatility of microwave ablation extends beyond tumor treatment, as it is also being researched for its potential use in managing cardiovascular conditions. Studies are exploring MWA’s ability to treat arrhythmias by ablating abnormal heart tissue that causes irregular heartbeats. As research into MWA’s applications continues, its use in a broader range of medical conditions is expected to expand, solidifying its position as a critical tool in minimally invasive medical treatments.

How Are Technological Advancements Impacting the Microwave Ablation Market?

Technological advancements are driving significant improvements in the efficacy, precision, and safety of microwave ablation, making it an increasingly attractive option for both clinicians and patients. One of the key advancements in microwave ablation technology is the development of more sophisticated, multi-probe systems that allow for the simultaneous ablation of multiple tumors. This is particularly important for patients with multifocal disease, such as those with multiple liver metastases or lung nodules. By using multiple probes, clinicians can treat larger areas or multiple tumors in a single session, reducing the need for repeat procedures and improving overall treatment efficiency. These multi-probe systems also allow for more uniform heating of the targeted tissue, ensuring that the entire tumor is effectively destroyed, which is crucial for reducing the risk of recurrence.

In addition to multi-probe systems, advancements in real-time imaging and guidance technologies are significantly enhancing the precision of microwave ablation procedures. High-resolution imaging modalities, such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), are being integrated with ablation systems to provide real-time visualization of the treatment area. This allows clinicians to accurately position the ablation probe and monitor the progress of the procedure, ensuring that the tumor is completely ablated while minimizing damage to surrounding healthy tissue. Real-time feedback also helps in adjusting the power and duration of microwave energy delivery, enhancing the safety and effectiveness of the procedure. These imaging advancements are particularly valuable for treating tumors located near critical structures, such as blood vessels or vital organs.

Another significant technological development is the refinement of microwave ablation probes. Modern ablation probes are designed to be thinner, more flexible, and more durable, making them easier to insert into the body and allowing for better maneuverability within tight or difficult-to-access areas. The use of smaller, more flexible probes reduces the risk of complications, such as bleeding or infection, and improves patient comfort during and after the procedure. Additionally, advancements in the cooling mechanisms of ablation probes have improved their efficiency in dissipating heat, allowing for higher power delivery without overheating surrounding tissues. These improvements in probe design are making microwave ablation safer and more effective, particularly for patients with tumors in delicate or challenging locations.

In the field of oncology, research into combining microwave ablation with other treatment modalities, such as immunotherapy and chemotherapy, is opening new possibilities for enhancing cancer treatment outcomes. Combining MWA with systemic therapies may improve the immune response to tumors or increase the effectiveness of chemotherapy by disrupting tumor cells and making them more vulnerable to drugs. This synergistic approach has the potential to offer more comprehensive and effective treatment strategies for patients with advanced or difficult-to-treat cancers. Clinical trials are ongoing to explore these combinations, and early results suggest that they could play an important role in the future of cancer care.

Advances in data analytics and artificial intelligence (AI) are also starting to impact the microwave ablation market. AI-driven software tools are being developed to assist clinicians in planning and optimizing ablation procedures. These tools can analyze patient data, including tumor size, location, and surrounding anatomy, to recommend the most appropriate ablation parameters and probe placement. By providing personalized treatment plans based on individual patient characteristics, AI can help ensure that the procedure is tailored to achieve the best possible outcome. Additionally, AI-based tools can assist in post-procedure monitoring by analyzing imaging data to detect residual tumor tissue or potential complications, improving long-term outcomes for patients.

Finally, advancements in portable microwave ablation systems are expanding the accessibility of this technology, particularly in outpatient settings and smaller medical facilities. Portable ablation units are compact, easy to transport, and can be set up in various healthcare environments, making it possible for more patients to benefit from this treatment option. As healthcare systems increasingly prioritize cost-effective and minimally invasive treatments, the availability of portable microwave ablation systems is expected to grow, enabling wider adoption of this technology in both urban and rural healthcare settings.

What Is Driving the Growth in the Microwave Ablation Market?

The growth in the microwave ablation market is driven by several key factors, including the rising global incidence of cancer, the increasing preference for minimally invasive treatments, and technological advancements that enhance the safety and efficacy of the procedure. One of the primary drivers is the growing burden of cancer worldwide. According to the World Health Organization (WHO), cancer remains a leading cause of death globally, with millions of new cases diagnosed each year. As the number of cancer patients continues to rise, there is increasing demand for effective treatment options that offer improved outcomes with minimal side effects. Microwave ablation provides an attractive alternative to traditional surgery for many patients, particularly those with inoperable tumors or those seeking less invasive treatment options.

The increasing preference for minimally invasive procedures is another significant factor contributing to the growth of the microwave ablation market. Patients and healthcare providers alike are seeking treatments that offer faster recovery times, fewer complications, and reduced hospital stays compared to traditional open surgeries. Microwave ablation fits these criteria, as it can be performed on an outpatient basis, often under local anesthesia, and typically results in less pain and a quicker return to normal activities. This trend toward minimally invasive treatments is particularly strong in oncology, where microwave ablation offers an alternative to more aggressive surgical approaches, especially for patients with early-stage cancers or those who are not candidates for surgery due to underlying health conditions.

Technological advancements in microwave ablation systems are also driving market growth by improving the precision, safety, and efficacy of the procedure. As new imaging and guidance technologies enhance the ability of clinicians to target tumors accurately and avoid healthy tissue, the adoption of microwave ablation is expanding. Furthermore, the development of more powerful and efficient ablation devices, combined with real-time monitoring capabilities, is making the procedure more accessible and effective across a wider range of tumor types and sizes. These technological innovations are helping to increase the adoption of microwave ablation in both hospital and outpatient settings, contributing to the overall growth of the market.

The increasing awareness and adoption of microwave ablation as a first-line treatment for certain cancers is also contributing to market expansion. Clinicians are recognizing the value of MWA for treating tumors that are difficult to access or located near critical structures, where traditional surgery may pose a higher risk. The ability of microwave ablation to treat tumors in multiple organs, including the liver, lungs, kidneys, and bones, makes it a versatile option in the treatment of various cancers. Additionally, as more clinical studies demonstrate the safety and efficacy of MWA in treating a wide range of tumors, its acceptance as a standard treatment option is growing.

The aging population and the increasing prevalence of chronic diseases such as liver disease, kidney disease, and lung disorders are further driving demand for microwave ablation. As the global population ages, the incidence of conditions that may lead to tumor development, such as cirrhosis and hepatitis, is rising. For many older patients or those with comorbidities, microwave ablation offers a safer, less invasive option compared to more aggressive surgical interventions. The growing number of patients with chronic diseases and comorbidities is expected to drive further adoption of MWA in oncology and other therapeutic areas.

In conclusion, the microwave ablation market is poised for significant growth driven by the rising global cancer burden, the increasing demand for minimally invasive treatments, and ongoing technological advancements that improve the safety, precision, and efficacy of the procedure. As healthcare providers continue to prioritize patient-centered, cost-effective treatments, the demand for microwave ablation is expected to flourish in the coming years, expanding its role in cancer treatment and beyond.

SCOPE OF STUDY:

The report analyzes the Microwave Ablation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Angio Dynamics
  • Boston Scientific Corporation
  • Emblation microwave
  • Huber+Suhner
  • Johnson & Johnson Services Inc.
  • Med Waves
  • Medtronic PLC
  • MedWaves Inc.
  • Miramar labs
  • Neu Wave Medical
  • Pearson Medical
  • Symple Surgical
  • Urologix
  • Vison Medical USA Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Microwave Ablation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cancer Propels Market Growth for Microwave Ablation Technologies
    • Increasing Adoption of Image-Guided Procedures Strengthens Business Case for Microwave Ablation
    • Rising Demand for Outpatient and Ambulatory Surgery Centers Bodes Well for Microwave Ablation Market Growth
    • Technological Innovations in Microwave Energy Delivery Systems Generate Market Growth
    • Increasing Use of Microwave Ablation in Cardiology Procedures Propels Demand
    • Increasing Adoption of Microwave Ablation for Pain Management Strengthens Market Opportunities
    • Growing Popularity of Microwave Ablation as a Treatment for Varicose Veins Spurs Market Growth
    • Advances in Microwave Antennas and Energy Distribution Propel Adoption in Surgical Procedures
    • Expanding Research in Microwave Ablation for Cardiac Arrhythmias Generates Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Microwave Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Microwave Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Microwave Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Liver Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Lung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Lung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Lung Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Microwave Ablation Market Analysis of Annual Sales in US$ for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: Japan 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: China 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Microwave Ablation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Microwave Ablation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Microwave Ablation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Europe 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: France 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: Germany 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Italy 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: UK 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 50: Spain Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Spain Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Spain 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 53: Russia Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Russia Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Russia 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of Europe Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Rest of Europe 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Microwave Ablation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Microwave Ablation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Asia-Pacific 15-Year Perspective for Microwave Ablation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Asia-Pacific 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 65: Australia Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Australia Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Australia 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 68: India Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: India Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: India 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 71: South Korea Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: South Korea Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: South Korea 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 74: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Asia-Pacific Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Rest of Asia-Pacific 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Microwave Ablation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Microwave Ablation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Latin America 15-Year Perspective for Microwave Ablation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 80: Latin America Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Latin America Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Latin America 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 83: Argentina Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Argentina Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Argentina 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 86: Brazil Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Brazil Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Brazil 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 89: Mexico Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Mexico Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Mexico 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 92: Rest of Latin America Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Latin America Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Latin America 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Microwave Ablation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Microwave Ablation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Middle East 15-Year Perspective for Microwave Ablation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 98: Middle East Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Middle East Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Middle East 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 101: Iran Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Iran Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Iran 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 104: Israel Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Israel Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Israel 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 107: Saudi Arabia Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Saudi Arabia Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Saudi Arabia 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 110: UAE Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UAE Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: UAE 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 113: Rest of Middle East Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Middle East Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Middle East 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Microwave Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 116: Africa Recent Past, Current & Future Analysis for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Africa Historic Review for Microwave Ablation by Application - Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: Africa 15-Year Perspective for Microwave Ablation by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION